102 related articles for article (PubMed ID: 2908853)
21. (+)-N-3-Benzyl-nirvanol and (-)-N-3-benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19.
Suzuki H; Kneller MB; Haining RL; Trager WF; Rettie AE
Drug Metab Dispos; 2002 Mar; 30(3):235-9. PubMed ID: 11854139
[TBL] [Abstract][Full Text] [Related]
22. Participation of a rat liver cytochrome P-450 induced by pregnenolone 16 alpha-carbonitrile and other compounds in the 4-hydroxylation of mephenytoin.
Shimada T; Guengerich FP
Mol Pharmacol; 1985 Aug; 28(2):215-9. PubMed ID: 4022003
[TBL] [Abstract][Full Text] [Related]
23. Species differences in stereoselective metabolism of mephenytoin by cytochrome P450 (CYP2C and CYP3A).
Yasumori T; Chen L; Nagata K; Yamazoe Y; Kato R
J Pharmacol Exp Ther; 1993 Jan; 264(1):89-94. PubMed ID: 8423554
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphism of human cytochrome P-450 (S)-mephenytoin 4-hydroxylase. Studies with human autoantibodies suggest a functionally altered cytochrome P-450 isozyme as cause of the genetic deficiency.
Meier UT; Meyer UA
Biochemistry; 1987 Dec; 26(25):8466-74. PubMed ID: 3442670
[TBL] [Abstract][Full Text] [Related]
25. Effects of eupatilin and jaceosidin on cytochrome p450 enzyme activities in human liver microsomes.
Ji HY; Kim SY; Kim DK; Jeong JH; Lee HS
Molecules; 2010 Sep; 15(9):6466-75. PubMed ID: 20877236
[TBL] [Abstract][Full Text] [Related]
26. A convenient assay for mephenytoin 4-hydroxylase activity of human liver microsomal cytochrome P-450.
Shimada T; Shea JP; Guengerich FP
Anal Biochem; 1985 May; 147(1):174-9. PubMed ID: 4025815
[TBL] [Abstract][Full Text] [Related]
27. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
[TBL] [Abstract][Full Text] [Related]
28. Mephenytoin hydroxylase activity in human liver: inhibition by steroids.
Jurima M; Inaba T; Kalow W
Drug Metab Dispos; 1985; 13(6):746-9. PubMed ID: 2867882
[No Abstract] [Full Text] [Related]
29. Gliclazide hydroxylation by rat liver microsomes.
Rieutord A; Stupans I; Shenfield GM; Gross AS
Xenobiotica; 1995 Dec; 25(12):1345-54. PubMed ID: 8719909
[TBL] [Abstract][Full Text] [Related]
30. Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities.
Ward SA; Walle T; Walle UK; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1989 Jan; 45(1):72-9. PubMed ID: 2910639
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of anticancer drugs on dextromethorphan-O-demethylase activity in human liver microsomes.
Le Guellec C; Lacarelle B; Catalin J; Durand A
Cancer Chemother Pharmacol; 1993; 32(6):491-5. PubMed ID: 8258200
[TBL] [Abstract][Full Text] [Related]
32. The role of S-mephenytoin hydroxylase (CYP2C19) in the metabolism of the antimalarial biguanides.
Wright JD; Helsby NA; Ward SA
Br J Clin Pharmacol; 1995 Apr; 39(4):441-4. PubMed ID: 7640152
[TBL] [Abstract][Full Text] [Related]
33. Potent inhibition of cytochrome P450IID6 (debrisoquin 4-hydroxylase) by flecainide in vitro and in vivo.
Haefeli WE; Bargetzi MJ; Follath F; Meyer UA
J Cardiovasc Pharmacol; 1990 May; 15(5):776-9. PubMed ID: 1692938
[TBL] [Abstract][Full Text] [Related]
34. Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.
Doecke CJ; Veronese ME; Pond SM; Miners JO; Birkett DJ; Sansom LN; McManus ME
Br J Clin Pharmacol; 1991 Feb; 31(2):125-30. PubMed ID: 2049228
[TBL] [Abstract][Full Text] [Related]
35. High-throughput radiometric CYP2C19 inhibition assay using tritiated (S)-mephenytoin.
Di Marco A; Cellucci A; Chaudhary A; Fonsi M; Laufer R
Drug Metab Dispos; 2007 Oct; 35(10):1737-43. PubMed ID: 17600081
[TBL] [Abstract][Full Text] [Related]
36. Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: a panel study.
Gram LF; Guentert TW; Grange S; Vistisen K; Brøsen K
Clin Pharmacol Ther; 1995 Jun; 57(6):670-7. PubMed ID: 7781267
[TBL] [Abstract][Full Text] [Related]
37. In vitro metabolism of the biguanide antimalarials in human liver microsomes: evidence for a role of the mephenytoin hydroxylase (P450 MP) enzyme.
Helsby NA; Ward SA; Howells RE; Breckenridge AM
Br J Clin Pharmacol; 1990 Aug; 30(2):287-91. PubMed ID: 2206791
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism of human cytochrome P-450.
Guengerich FP; Umbenhauer DR; Churchill PF; Beaune PH; Böcker R; Knodell RG; Martin MV; Lloyd RS
Xenobiotica; 1987 Mar; 17(3):311-6. PubMed ID: 3577206
[TBL] [Abstract][Full Text] [Related]
39. Substrate specificity of the form of cytochrome P-450 catalyzing the 4-hydroxylation of debrisoquine in man.
Boobis AR; Murray S; Kahn GC; Robertz GM; Davies DS
Mol Pharmacol; 1983 Mar; 23(2):474-81. PubMed ID: 6220203
[TBL] [Abstract][Full Text] [Related]
40. The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.
Fischer V; Vickers AE; Heitz F; Mahadevan S; Baldeck JP; Minery P; Tynes R
Drug Metab Dispos; 1994; 22(2):269-74. PubMed ID: 8013282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
